Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases
HONG KONG, GERMANTOWN, MD & SUZHOU BIOBAY, CHINA, July 23, 2024 - (ACN Newswire) – Sirnaomics Ltd. (HKG: 2257), 'Sirnaomics'...